Crystal and X-ray powder diffraction data for cefotaxime sodium salt, C 16 H 16 N 5 NaO 7 S 2
Source abstract
Abstract
An indexed powder diffraction pattern and related crystallographic data are reported for cefotaxime sodium salt: 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2amino-4-thiazolyl)(methoxyimino)-acetyl]amino]-8-oxo, monosodium salt, [6 R −[6α,7β( Z )]], C 16 H 16 N 5 NaO 7 S 2 . The unit cell dimensions were determined from diffractometer methods, using monochromatic CuK α 1 radiation, and evaluated by indexing programs. The monoclinic cell found for cefotaxime sodium was a =13.063(2) Å, b =8.916(2) Å, c =9.726(2) Å, β=107.34(2)°, Z =2, space groups: P 2 1 (No. 4) or P 2 1 / m (No. 11), D x =1.467 g / cm 3 .
Source: crossref · Quality: baseline
Research context
OpenAlex topics: X-ray Diffraction in Crystallography · Crystallography and molecular interactions · Cultural Heritage Materials Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (7)
Show source-provided references
1. 10.1107/S002188988501051210.1107/S0021889885010512 ↗
2. Siemens D5000/DIFFRAC-AT Version 3.2. (1993). Siemens Analytical X-ray Instruments, Inc., Karlsruhe, Germany.
3. 10.1107/S002188986800508X10.1107/S002188986800508X ↗
4. Martindale: The Extra Pharmacopoeia (1989). 29th ed. Reynolds, J. E. F. (Ed). The Pharmaceutical Press, London, pp. 151–156.
5. U.S. Pharmacopoeia National Formulary. USP XXII. (1990). US Pharmacopoeial Convention, Easton, PA.
6. 10.6028/NBS.TN.114110.6028/NBS.TN.1141 ↗
7. 10.1107/S002188987901178X10.1107/S002188987901178X ↗